Filing Details
- Accession Number:
- 0001104659-21-076353
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-03 16:03:44
- Reporting Period:
- 2021-06-01
- Accepted Time:
- 2021-06-03 16:03:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613859 | Pra Health Sciences Inc. | PRAH | Services-Commercial Physical & Biological Research (8731) | 463640387 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1738327 | J. Michael Bonello | C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-01 | 4,823 | $0.00 | 24,051 | No | 4 | A | Direct | |
Common Stock | Disposition | 2021-06-01 | 1,278 | $170.45 | 22,773 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-06-01 | 906 | $170.45 | 21,867 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2021-06-01 | 2,823 | $0.00 | 2,823 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2021-06-01 | 2,000 | $0.00 | 2,000 | $0.00 |
Common Stock | Restricted Stock Unit | Acquisiton | 2021-06-01 | 14,008 | $0.00 | 14,008 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,647 | No | 4 | M | Direct | ||
2,000 | No | 4 | M | Direct | ||
14,008 | No | 4 | A | Direct |
Footnotes
- Represents the vesting of two separate tranches of restricted stock units granted on June 1, 2020.
- Represents the number of shares required to be sold by the reporting person to satisfy tax withholding obligations related to the vesting of 2,823 restricted stock units from a June 1, 2020 grant of 8,470 restricted stock units which, upon vesting, convert into Issuer's common stock on a one-for-one basis under the PRA Health Sciences, Inc. 2020 Stock Incentive Plan. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Represents the number of shares required to be sold by the reporting person to satisfy tax withholding obligations related to the vesting of 2,000 restricted stock units from a June 1, 2020 grant of 4,000 restricted stock units which, upon vesting, convert into Issuer's common stock on a one-for-one basis under the PRA Health Sciences, Inc. 2020 Stock Incentive Plan. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Restricted stock units were granted on June 1, 2020 and convert into Issuer's common stock on a one-for one basis in an amount equal to one-third of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.
- Not applicable.
- Restricted stock units were granted on June 1, 2020 and convert into Issuer's common stock on a one-for one basis in an amount equal to 50% of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.
- Restricted stock units convert into the Issuer's common stock on a one-for-one basis in an amount equal to one-third of the total amount per year on each anniversary of the grant date, subject to the holder's continued service through each vesting date.